Literature DB >> 714688

[Comparative studies on the action of aminoglycosides and cephalosporins on the proximal tubule of the human kidney (author's transl)].

A W Mondorf.   

Abstract

Tubulo-toxic effects of drugs can be recognised by the elimination of portions of brush border membrane in the urine. An integral constituent of the brush border membrane is an alanine aminopeptidas (AAP). It is measurable in the urine enzymatically and immunologically with great reliability. The AAP activity was determined in the 24-hour urine of test subjects. Fifteen subjects received 3 mg/kg gentamicin, sisomicin or tobramycin on 3 consecutive days and 10 subjects were given amikacin (15 mg/kg). In addition, 15 subjects received cephacetrile (8.0 g), cephazolin (6.0 g) or cephalothin (8.0 g) on 3 consecutive days. It was shown that all aminoglycosides have a cumulative effect on the brush border membrane, amikacin is the strongest and tobramycin the weakest. The cephalosporins cephalothin and cephazolin were indifferent to the tubule membranes and had no effect on the excretion of AAP. There were responders and non-responders to cephacetrile. The application of cephalothin and cephazolin immediately before the administration of gentamicin prevents the membrane effect of gentamicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 714688

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  2 in total

1.  Non-linear tissue binding of amikacin in rats: the effect of renal impairment.

Authors:  I G Alonso; J M Lanao; M C Saez; A A Dominguez-Gil; A Dominguez-Gil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

2.  Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.

Authors:  J M Gatell; J G SanMiguel; V Araujo; L Zamora; J Maña; M Ferrer; M Bonet; M Bohe; M T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.